Intracellular calcium signalling in striated muscle cells

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 7, 1997, Pages 559-568

  Lunde, P K ^a   Sejersted, O M ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; MEMBRANE PROTEIN; RYANODINE RECEPTOR;

ANIMAL TISSUE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; DEPOLARIZATION; HEART; HEART FAILURE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MALIGNANT HYPERTHERMIA; MUSCLE FATIGUE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALIA;

EID: 0030713377     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709055278     Document Type: Review

References (72)

1. Siesjö BK, Siesjö P. Mechanisms of secondary brain injury. Eur J Anaesthesiol 1996; 13: 247-68.
2. Pierce GN, Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol 1995; 27: 53-63.
3. Hardingham GE, Chawla S, Johnson CM, Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997; 385: 260-5.
4. Gerasimenko OV, Gerasimenko JV, Tepikin AV, Petersen OH. Calcium transport pathways in the nucleus. Pflugers Arch 1996; 432: 1-6.
5. 2+ exchanger isoforms. J Biol Chem 1994; 269: 14849-52.
6. Sheu S-S, Blaustein MP. Sodium/calcium exchange and control of cell calcium and contractility in cardiac and smooth muscle. In: Fozzard HA, Haber E, Jennings RB, Katz AM, editors. The heart and cardiovascular system. New York: Raven Press, 1991: 903-44.
7. i, a cellular or tissue basis, a property unique to the Langendorff perfused heart? A bundle of contradictions. J Mol Cell Cardiol 1991; 23: 773-7.
8. Berridge MJ. Elementary and global aspects of calcium signalling. J Physiol 1997; 499.2: 291-306.
9. Marks AR. Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 1997; 272: H597-H605.
10. Kupferman R, Mitra PP, Hohenberg PC, Wang SS-H. Analytical calculation of intracellular calcium wave characteristics. Biophys J 1997; 72: 2430-44.
11. Takamatsu T, Wier WG. Calcium waves in mammalian heart: quantification of origin, magnitude, waveform and velocity. FASEB J 1990; 4: 1519-25.
12. 2+ excitability of the endoplasmic reticulum. Mol Biol Cell 1995; 6: 945-51.
13. 2+ oscillations. Am J Physiol 1995; 269: C1079-C1092.
14. Sneyd J, Keizer J, Sanderson MJ. Mechanisms of calcium oscillations and waves: a quantitative analysis. FASEB J 1995; 9: 1463-72.
15. Joseph SK. The inositol triphosphate receptor family. Cell Signal 1996; 8: 1-7.
16. Michikawa T, Miyawaki A, Furuichi T, Mikoshiba K. Inositol 1,4,5-trisphosphate receptors and calcium signaling. Crit Rev Neurobiol 1996; 10: 39-55.
17. Ashley RH. Intracellular calcium channels. Essays Biochem 1995; 30: 97-117.
18. 3) receptor. J Membr Biol 1995; 145: 205-16.
19. Shomer NH, Louis CF, Fill M, Litterer LA, Mickelson JR. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor. Am J Physiol 1993; 264: C125-C135.
20. Pessah IN, Waterhouse AL, Casida JE. The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun 1985; 128: 449-56.
21. 2+ channel activity. J Bioenerg Biomembr 1989; 21: 227-46.
22. Jenden DJ, Fairhurst AS. The pharmacology of ryanodine. Pharmacol Rev 1969; 21: 1-25.
23. Franzini-Armstrong C. Studies of the triad. J Cell Biol 1970; 47: 488-99.
24. Inui M, Saito A, Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem 1987; 262: 1740-7.
25. Wagenknecht T, Grassucci R, Frank J, Saito A, Inui M, Fleischer S. Three-dimensional architecture of the calcium channel/foot structure of sarcoplasmic reticulum. Nature 1989; 338: 167-70.
26. Ledbetter MW, Freiner JK, Louis CF, Mickelson JR. Tissue distribution of ryanodine receptor isoforms and alleles determined by reverse transcription polymerase chain reaction. J Biol Chem 1994; 269: 31544-51.
27. 2+ release channels: does diversity in form equal diversity in function? Physiol Rev 1996; 76: 1027-71.
28. Otsu K, Fujii J, Periasamy M, Difilippantonio M, Uppender M, Ward DC, Maclennan DH. Chromosome mapping of five humman cardiac and skeletal muscle sarcoplasmic reticulum protein genes. Genomics 1993; 17: 507-9.
29. Chu A, Diaz-Muñoz M, Hawkes MJ, Brush K, Hamilton SL. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Mol Pharmacol 1990; 37: 735-41.
30. Lunde PK, Sejersted OM. Ryanodine binding sites measured in small skeletal muscle biopsies. Scand J Clin Lab Invest 1997; 57: 569-80.
31. +-transport in skeletal muscle. Physiol Rev 1986; 66: 542-80.
32. Lipp P, Niggli E. Submicroscopic calcium signals as fundamental events of excitation-contraction coupling in guinea-pig cardiac myocytes. J Physiol 1996; 492: 31-8.
33. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983; 245: C1-C14.
34. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 1993; 262: 740-4.
35. 2+ sparks in frog skeletal muscle. J Physiol 1997; 502.1: 3-11.
36. Armstrong CM, Bezanilla FM, Horowicz P. Twitches in the presence of ethylene glycol bis(-aminoethyl ether)-N, N'-tetraacetic acid. Biochim Biophys Acta 1972; 267: 605-8.
37. Ríos E, Pizarro G. Voltage sensor of exitation-contraction coupling in skeletal muscle. Physiol Rev 1991; 71: 849-908.
38. Ríos E, Pizarro G, Stefani E. Charge movement and the nature of signal transduction in skeletal muscle excitation-contraction coupling. A Rev Physiol 1992; 54: 109-33.
39. Marks AR. Cellular functions of immunophilins. Physiol Rev 1996; 76: 631-49.
40. Knudson CM, Stang KK, Moomaw CR, Slaughter CA, Campbell KP. Primary structure and topological analysis of a skeletal musclespecific Junctional sarcoplasmic reticulum glycoprotein (Triadin). J Biol Chem 1993; 268: 12646-54.
41. Caswell AH, Brandt NR, Brunschwig J-P, Purkerson S. Localization and partial characterization of the oligomeric disulfide-linked molecular weight 95000 protein (Triadin) which binds the ryanodine and dihydropyridine receptors in skeletal muscle triadic vesicles. Biochemistry 1991; 30: 7507-13.
42. Zhu JQ, Howlett SE, Ferrier GR. A role for cAMP in activation of the voltage-sensitive release mechanism for cardiac contraction [Abstract]. Biophys J 1997; 72: a161.
43. Levi AJ, Ferrier GR. Ca release activated by membrane depolarization in the absence of Ca entry in mammalian heart [Abstract]. Biophys J 1997; 72: a161.
44. Leblanc N, Hume JR. Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum. Science 1990; 248: 372-6.
45. Lederer WJ, Niggli E, Hadley RW. Sodiumcalcium exchange in excitable cells: fuzzy space. Science 1990; 248: 283.
46. Wasserstrom JA, Vites AM. The role of Na-Ca exchange in activation of excitation-contraction coupling in rat ventricular myocytes. J Physiol 1996; 493: 529-42.
47. Rosenberg H. Clinical presentation of malignant hyperthermia. Br J Anaesth 1988; 60: 268-73.
48. Gronert GA. Malignant hyperthermia. Anesthesiology 1980; 53: 395-423.
49. Ellis KO, Castellion AW, Honkomp LJ, Wessels FL, Carpenter JF, Halliday RP. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci 1989; 62: 948-51.
50. Nelson TE. SR function in malignant hyper-thermia. Cell Calcium 1988; 9: 257-65.
51. Harbitz I, Kristensen T, Bosnes M, Kran S, Davies W. DNA sequence of the skeletal muscle calcium release channel cDNA and verification of the Arg615→Cys615 mutation, associated with porcine malignant hyperthermia, in Norwegian landrace pigs. Anim Genet 1992; 23: 395-402.
52. Fagerlund T, Ording H, Bendixen D, Islander G, Ranklev-Twetman E, Berg K. RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clin Genet 1996; 49: 186-8.
53. Fagerlund T, Ording H, Bendixen D, Berg K. Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyper-thermia. Clin Genet 1994; 46: 401-4.
54. Fagerlund T, Islander G, Ranklev E, Harbitz I, Hauge JG, Mokleby E, Berg K. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet 1992; 41: 270-2.
55. 2+ regulation defects. Physiol Rev 1996; 2: 537-92.
56. Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 1988; 263: 9310-5.
57. Mygland A, Tysnes OB, Aarli JA, Flood PR, Gilhus NE. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J Neuroimmunol 1992; 37: 1-7.
58. Skeie GO, Bartoccioni E, Evoli A, Aarli JA, Gilhus NE. Ryanodine receptor antibodies are associated with severe myasthenia gravis. Eur J Neurol 1996; 3: 136-40.
59. 3H]-ryanodine to sarcoplasmic reticulum. Muscle Nerve 1997.
60. Dhalla N, Wang X, Beamish RE. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol 1996; 1: 7-20.
61. i, handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J 1995; 129: 684-9.
62. del Monte F, O'Gara P, Poole-Wilson PA, Yacoub M, Harding SE. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res 1995; 30: 281-90.
63. Figueredo VM, Camacho SA. Basic mechanisms of myocardial dysfunction: cellular pathophysiology of heart failure. Curr Opin Cardiol 1995; 10: 246-52.
64. Gwathmey JK, Liao R, Helm PA, Gowriharan T, Hajjar RJ. Is contractility depressed in the failing human heart? Cardiovasc Drugs Ther 1995; 9: 581-7.
65. Capasso JM, Li P, Anversa P. Cytosolic calcium transients in myocytes isolated from rats with ischemic heart failure. Am J Physiol 1993; 265: H1953-H1964.
66. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995; 95: 888-94.
67. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997; 276: 800-6.
68. Westerblad H, Lee JA, Lännergren J, Allen DG. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol 1991; 261: C195-209.
69. 2+ release in single fibres of mouse skeletal muscle. J Physiol 1997; 498: 587-600.
70. Balnave CD, Allen DG. Intracellular calcium and force in single mouse muscle fibres following repeated contractions with stretch. J Physiol 1995; 488: 25-36.
71. 2+] in the development of low frequency fa tigue in mouse single muscle fibres. J Physiol 1996; 491: 813-24.
72. 2+ handling in rat cardiomyocytes: effects on shortening and relaxation. Am J Physiol 1997; 273: H573-82.